drugset / Trial / NCT00606541
An Open Label, Double-blind Discontinuation Study of Quetiapine Extended Release(XR)
RandomizedParallel-groupQuadruple-blindPrevention
Summary
Purpose of Study: To examine 1) the short and long-term effectiveness and tolerability of quetiapine (extended release) XR for the treatment of social anxiety disorder (SAD); and 2) continuation effects of quetiapine XR in preventing SAD relapse.
Timeline
- Start
- 2008-01
- Primary completion
- 2011-12
- Completion
- 2012-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Quetiapine | Small molecule | 50 mg | — |
| Subject | Quetiapine | Small molecule | 400 mg | — |